smart business., page-3

The last few pages of the report show increasing sale and decreasing cost. Reasonable to assume furhter profit growth next year. If it doubles and a sector PE of 20 then this time next year Market cap should be around 24 million. $ times current value.

Whilst itr is still 2 away, the big kicker here is the hundred million dollar market for Liver Fibrosous. Because this is an auto generated scalable software business, last years costs were only $1.8 million.

After product development and sale costs, it could stay at that level and generate in excess of #100 million in saleS.

What a great business model. The money keeps chinging in for years on auto-pilot. Will still be a few years yet, but qa good growth stock for the super fund.

That means a valuation of around $6 in 5 years, good easy stroll from 2 cents over that time. Does not appear to be all that risky as they have already got experience and profits.

PoS.